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354Derivation and validation of a practical risk score for
prediction of mortality after open repair of ruptured
abdominal aortic aneurysms in a U.S. regional
cohort and comparison to existing scoring systems
William P. Robinson, MD,a Andres Schanzer, MD,a YouFu Li, MD,a Philip P. Goodney, MD, MS,b,c
Brian W. Nolan, MD, MS,b,c Mohammad H. Eslami, MD,d Jack L. Cronenwett, MD,b,c and
Louis M. Messina, MD,a Worcester and Boston, Mass; and Lebanon and Hanover, NH
Objective: Scoring systems for predicting mortality after repair of ruptured abdominal aortic aneurysms (RAAAs) have not
been developed or tested in a United States population and may not be accurate in the endovascular era. Using
prospectively collected data from the Vascular Study Group of New England (VSGNE), we developed a practical risk
score for in-hospital mortality after open repair of RAAAs and compared its performance to that of the Glasgow aneu-
rysm score, Hardman index, Vancouver score, and Edinburg ruptured aneurysm score.
Methods: Univariate analysis followed by multivariable analysis of patient, prehospital, anatomic, and procedural char-
acteristics identiﬁed signiﬁcant predictors of in-hospital mortality. Integer points were derived from the odds ratio (OR)
for mortality based on each independent predictor in order to generate a VSGNE RAAA risk score, which was internally
validated using bootstrapping methodology. Discrimination and calibration of all models were assessed by calculating the
area under the receiver-operating characteristic curve (C-statistic) and applying the Hosmer-Lemeshow test.
Results: From 2003 to 2009, 242 patients underwent open repair of RAAAs at 10 centers. In-hospital mortality was 38%
(n[ 91). Independent predictors of mortality included age >76 years (OR, 5.3; 95% conﬁdence interval [CI], 2.8-10.1),
preoperative cardiac arrest (OR, 4.3; 95% CI, 1.6-12), loss of consciousness (OR, 2.6; 95% CI, 1.2-6), and suprarenal
aortic clamp (OR, 2.4; 95% CI, 1.3-4.6). Patient stratiﬁcation according to the VSGNE RAAA risk score (range, 0-6)
accurately predicted mortality and identiﬁed those at low and high risk for death (8%, 25%, 37%, 60%, 80%, and 87% for
scores of 0, 1, 2, 3, 4, and $5, respectively). Discrimination (C [ .79) and calibration (c2 [ 1.96; P [ .85) were
excellent in the derivation and bootstrap samples and superior to that of existing scoring systems. The Glasgow aneurysm
score, Hardman index, Vancouver score, and Edinburg ruptured aneurysm score correlated with mortality in the VSGNE
cohort but failed to identify accurately patients with a risk of mortality >65%.
Conclusions: Existing scoring systems predict mortality after RAAA repair in this cohort but do not identify patients at
highest risk. This parsimonious VSGNE RAAA risk score based on four variables readily assessed at the time of
presentation allows accurate prediction of in-hospital mortality after open repair of RAAAs, including identiﬁcation of
those patients at highest risk for postoperative mortality. (J Vasc Surg 2013;57:354-61.)Ruptured abdominal aortic aneurysm (RAAA) accounts
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Scoring systems have been developed in Canada and the
United Kingdom to predict mortality after open repair of
RAAAs, including the Glasgow aneurysm score (GAS),
theHardman index, the Vancouver score, and the Edinburg
ruptured aneurysm score (ERAS).12-15 However, these
scoring systems may be unsuitable for widespread applica-
tion due to unproven generalizability. First, scoring systems
for predicting mortality after open repair of RAAAs have
never been developed nor tested in a U.S. population.
Second, existing scoring systems have not been validated
consistently or robustly.16-19 Third, it is not known if pub-
lished prediction models are accurate in the current era,
which incorporates the increasing and preferential use of
endovascular repair (EVAR) of RAAAs when possible.1,3
In modern practice, patients may be selected for open repair
because they have difﬁcult anatomy or hemodynamic insta-
bility, which makes them unsuitable for EVAR. Thus,
patients undergoing open repair of a RAAA in the current
era may be at higher risk for mortality than those who
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patients currently treated with open repair may be at higher
baseline risk than those treated with EVAR, which
confounds comparisons of current outcomes.1,19-21 Our
objective was to examine the mortality and clinical variables
that correlated with mortality after open repair of RAAA in
a contemporary U.S. regional cohort, the Vascular Study
Group of New England (VSGNE). We sought to develop
a practical risk score for prediction of in-hospital mortality
after open repair RAAA using prospectively acquired data
from the VSGNE and to compare the performance of this
risk score to existing scoring systems. We hypothesized
that a risk score to predict mortality after open repair of
RAAAs based on contemporary outcomes is superior to
that of existing risk scores based on non-U.S., noncontem-
porary outcomes.
METHODS
Database and data collection. The VSGNE is a
regional cooperative quality improvement initiative devel-
oped in 2002 to study regional outcomes in vascular
surgery. Details regarding this registry have been published
previously.22 Trained nurses or clinical abstractors entered
data prospectively on >100 clinical and demographic
variables (www.VSGNE.org). Research analysts were
blinded to patient, surgeon, and hospital identity.
Subjects. Our cohort included all patients who under-
went open repair of RAAAs from 2003 to 2009 at 10
centers, both community and academic, involved in the
registry. All patients in the VSGNE were evaluated for pre-
existing demographic variables and medical comorbidities
as well as parameters reﬂective of preoperative severity of
illness, including lowest preintubation systolic blood pres-
sure (SBP), mental status, history of preoperative cardiac
arrest, hemoglobin, and creatinine. Prehospital characteris-
tics, including transfer status, time from symptoms to inci-
sion, and time from admission to incision, also are
recorded. The VSGNE also collects detailed anatomic
and procedural information, such as AAA size, aortic clamp
position, renal/visceral ischemic time, estimated blood
loss, procedural time, exposure, anastomotic sites, graft
size and conﬁguration, patency of inferior mesenteric artery
and hypogastric arteries, use of heparin, mannitol, and
renal perfusion, and transfusion of crystalloid and blood
products. The VSGNE tracks outcomes including in-
hospital mortality and long-term mortality by matching
patients with the Social Security Death Index.
Statistical analysis. Descriptive statistics were used to
analyze patient, prehospital, anatomic, and procedural char-
acteristics. Univariate analysis of patient comorbidities, pre-
hospital factors including time to incision, anatomic
parameters, and procedural variables associated with in-
hospital mortality were performed with a logistic regression
model. The impact of age on mortality was analyzed with
univariate andmultivariable regression according tomultiple
strata of age, with the odds ratio (OR) ofmortality calculated
with the stratum “age <60” used as the reference pop-
ulation. The Youden index ([sensitivity þ speciﬁcity] – 1) isa frequently used summarymeasure of the receiver-operating
characteristic curve, which enables the selection of an optimal
threshold value (cutoff point) for the impact of a continuous
variable on an outcome.23 A higher Youden index reﬂects
more accurate predictive ability at a speciﬁc cutoff point. In
order to identify the optimal cutoff point for determining the
impact of age on mortality, a Youden index and the percent
of patients classiﬁed correctly were determined for each
cutoff point of increasing age.
Variables associated with mortality on univariate anal-
ysis (P # .2) were initially included in a multivariable
regression model, which used stepwise elimination in order
to identify variables independently predictive of mortality.
We then generated an integer-based VSGNE RAAA risk
score based on signiﬁcant predictors of mortality on multi-
variable regression. We determined the integer points
assigned to each signiﬁcant predictor by dividing its indi-
vidual OR for mortality by a common denominator of
2.5 and rounding to the nearest integer. The calibration
of the VSGNE RAAA risk score model was tested by
applying the model to all individual patients in the dataset
and comparing observed and expected mortality across
strata of predicted risk. A Hosmer-Lemeshow goodness-
of-ﬁt statistic was calculated. The discrimination of the
VSGNE RAAA risk score was evaluated via the area under
the receiver-operating characteristic curve (AUC). Boot-
strapping methodology was used to internally validate the
VSGNE RAAA risk score.24 We randomly drew with
replacement 1000 random samples of 100%. The AUC
was calculated for each sample and compared to the
AUC in the original dataset in order to assess the reproduc-
ibility of the VSGNE RAAA risk score model.
The GAS, Hardman index, Vancouver score, and
ERAS were calculated for each patient in the VSGNE
cohort in order to determine the performance of each
scoring system in predicting mortality. The ability of each
of the existing scoring systems to identify patients of
varying mortality risk was determined by calculating patient
mortality in the VSGNE cohort for each stratum of
increasing risk scores, which represent increasing predicted
risk of mortality, in each of the existing scoring systems.
The discrimination of each scoring system was assessed in
the VSGNE cohort via the AUC, and the calibration of
each model was assessed via the Hosmer-Lemeshow test.
An a ¼ .05, corresponding to P ¼ .05 and 95% conﬁdence
intervals (CIs), was used as a criterion for statistical signif-
icance. Statistical computations were performed using SAS
software (version 9.1; SAS Institute, Cary, NC).
RESULTS
Patient and prehospital characteristics. Two hun-
dred forty-two patients underwent open repair of an
RAAA in 10 academic and community hospitals partici-
pating in the VSGNE from 2003 to 2009. The number of
repairs over the study period varied according to center
(mean [standard deviation] 24.2 [25]; median, 15.5; range,
1-79). Four centers performed six or fewer repairs, two
centers performed 15 to 16 repairs, and four centers
Table I. Patient demographics, comorbidities, and
prehospital characteristics
Characteristic No. (%)a
Male 205 (85.1)
Caucasian 240 (99.6)
Age >76 105 (43.4)
Preoperative heart rate >100 bpm 47 (19.4)
Systolic blood pressure <90 mm Hg 135 (55.8)
Altered mental status 93 (38.4)
Preoperative loss of consciousness 48 (20.4)
Preoperative cardiac arrest 33 (13.9)
Hypertension 187 (81.1)
Diabetes mellitus 36 (15.6)
Coronary artery disease 74 (33.8)
Congestive heart failure 26 (11.6)
Coronary artery bypass graft/percutaneous
transluminal coronary angioplasty
54 (23.9)
Smoking 191 (87.2)
Chronic obstructive pulmonary disease 96 (42.1)
Creatinine >2.1 mg/dL (190 mmol/L) 20 (9.4)
Creatine (mg/dL)a 1.4  0.7
Dialysis 1 (0.4)
Cerebrovascular disease 14 (6.2)
Hemoglobin (g/dL)a 11.2  2.3
b-blocker 88 (38.4)
Acetylsalicylic acid or Plavix 110 (45.5)
Statin 74 (33.0)
Prior aortic surgery 10 (4.1)
Transferred from outside facility 132 (54.6)
Time from symptom onset to incision, hours,
median (IQR)
6 (10.5)
Time from admission to incision, hours, median
(IQR)
1 (2)
IQR, Interquartile range.
aOther units are expressed as mean (standard deviation) except as indicated.
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patients had symptoms and signs of severe shock, including
a preoperative heart rate >100 bpm (20%), preoperative
SBP<90mmHg (56%), altered mental status (38%), loss of
consciousness (20%), and cardiac arrest (14%; Table I).
Anatomic andprocedural characteristics. Themajority
of patients were repaired with a transperitoneal approach
(95%) and tube graft (67%). The proximal aortic cross-
clamp was placed in the infrarenal location in 141 patients
(59%) and suprarenal in 98 patients (41%; Table II).
Factors associated with mortality. There were 91 in-
hospital deaths (38%).No single risk factor or combination of
two factors universally predicted mortality on univariate
analysis (Table III). For example, eight of 33 patients who
suffered preoperative cardiac arrest survived, including two
patients who were older than 76 years. Transfer status, time
from symptoms to incision, and time from admission to
incision did not impact mortality. Increasing age was
generally correlated with increased mortality, although
patients in the highest stratum of age (age>85) did not have
the highest risk of mortality (Table IV). A cutoff point of 76
years of age yielded the highest Youden index (.38) of any
age cutoff point and correctly predicted mortality for 70% of
patients, thereby identifying age >76 years as the optimal
threshold for analyzing the impact of age on mortality. On
multivariable analysis in which age was modeled as a dichot-
omous variable as either age >76 years or age #76 years,
independent predictors of mortality included age>76 years,
preoperative cardiac arrest, loss of consciousness on presen-
tation, and need for suprarenal aortic clamp (Table V).
Derivation and validation of the VSGNE RAAA
risk score. The VSGNE RAAA risk score (range, 0-6) was
calculated for each patient by totaling the integer points
assigned to each independent predictor of mortality
(Table VI). The odds of mortality with each integer
increase in risk score increased by a factor of 2.3 (95% CI,
1.79-2.95). Table VII lists the number of patients and the
mortality rate in each stratum of VSGNERAAA risk score. A
linear relationship of VSGNE risk score to postoperative
mortality was identiﬁed (Fig 1). A VSGNE RAAA risk score
of 4 identiﬁed patients with an 80% risk of mortality,
whereas a VSGNE RAAA risk score $5 identiﬁed patients
with an 87% risk of mortality. Discrimination of the VSGNE
RAAA risk score in the VSGNE cohort as measured by the
AUC was excellent (C ¼ .79; 95% CI, .73-.85). A Hosmer-
Lemeshow goodness-of-ﬁt test was not statistically signiﬁ-
cant, indicating good calibration of the model (c2 [5
degrees of freedom] ¼ 1.96; P ¼ .85). The VSGNE RAAA
risk score model was then applied to 1000 bootstrap samples
and showed excellent discrimination (C ¼ .79; 95% CI,
.73-.85). In the bootstrap datasets, the odds of mortality
with each integer increase in risk score increased by a factor
of 2.4 (95% CI, 1.83-3.07). The VSGNE RAAA risk score
calculator is available online at www.vsgne.org.
Performance of existing scoring systems in the
VSGNE dataset. The GAS, Hardman index, Vancouver
score, and ERAS were calculated for all patients in the
VSGNE cohort according to their respective formulas(Table VIII). The AUC for each of the existing scoring
systems ranged from .67 to .74 in the VSGNE dataset, and
model calibration was acceptable as evidenced by nonsig-
niﬁcant Hosmer-Lemeshow tests (Table IX). When
analyzed according to strata of increasing score (and
associated increasing predicted risk of mortality), the ability
of each existing scoring system score to predict mortality in
the VSGNE dataset was most acceptable in low-risk
patients (Fig 2). The GAS, Hardman index, Vancouver
score, and ERAS failed to discriminate patients who
have >50% mortality risk and failed to identify any patient
with >65% risk of mortality (Fig 2).
DISCUSSION
Accurate prediction of mortality after open repair of
RAAAs is important for three reasons. First, prognostic
tools aid clinical decision making, including the decision
to avoid repair in patients with prohibitive risk. Because
no existing scoring system has gained widespread accep-
tance, clinical decisions are often still based primarily on
subjective criteria, which may vary widely within and
between centers.15 Second, risk adjustment should allow
objective evaluation of open RAAA repair in the endovas-
cular era and help control for the selection bias that
confounds comparison of open and endovascular RAAA
Table II. Anatomic and procedural characteristics
Characteristic No. (%)a
Average aneurysm diameter, cm 7.7  2.1
Aneurysm diameter, cm
<5 11 (5.3)
5-7.5 85 (40.9)
7.5-10 75 (36.1)
>10 37 (17.8)
Transperitoneal exposure 231 (95.4)
Retroperitoneal exposure 11 (4.6)
Infrarenal clamp 141 (59)
Suprarenal clamp 98 (41)
Inferior mesenteric artery
Occluded 147 (64.8)
Ligated 76 (33.5)
Reimplanted 4 (1.8)
Tube graft 158 (67.2)
Aortobi-iliac 47 (20)
Aortobifemoral 29 (12.3)
Heparin administered 135 (56.7)
Mannitol administered 64 (27.0)
Estimated blood loss, L 4.7  7.2
Units packed red blood cells transfused 6.7  6.1
Autotransfusion, L 1.7  1.7
Crystalloid infused, L 7.9  6.4
Procedural time, minutes 187.4  85.0
Delayed abdominal closure 55 (25.5)
aOther units are expressed as mean (standard deviation).
Table III. Univariate predictors of in-hospital mortality
Variable OR 95% CI P value
Age >76 4.6 2.6-8 <.0001
Cardiac arrest 6.8 2.9-16 <.0001
Loss of consciousness 4.2 2.1-8.3 <.0001
Suprarenal aortic
clamp
2.3 1.3-2.8 .003
Female 2.1 1.0-4.3 .04
Hypertension 1.8 0.9-3.8 .12
Creatinine >
2.15 mg/dL
2.4 0.9-6.1 .064
Lowest preoperative
systolic blood
pressure <
80 mm Hg
3.2 1.8-5.4 <.0001
Congestive heart
failure
1.8 0.8-4.0 .18
CI, Conﬁdence interval; OR, odds ratio.
Table IV. Impact of age on in-hospital mortality
Age strata n
Univariate analysis Multivariable analysis
OR 95% CI P value OR 95% CI P value
<60 11 0.2 0.02-1.3 .08 Ref
60-69 65 2.3 0.3-19.4 .5 1.3 0.1-11.6 .8
70-79 104 6.5 0.8-52.8 .08 4.3 0.5-35.7 .2
80-85 38 19.2 2.2-167.1 .01 17.2 1.9-15.3 .01
>85 24 10.0 1.1-90.8 .04 8.6 0.9-80.9 .06
CI, Conﬁdence interval; OR, odds ratio.
Table V. Multivariable predictors of in-hospital mortality
Variable OR 95% CI P value
Age >76 5.3 2.8-10.1 <.0001
Cardiac arrest 4.3 1.6-12.0 .0048
Loss of consciousness 2.7 1.2-6.0 .018
Suprarenal aortic
clamp
2.4 1.3-4.6 .0057
CI, Conﬁdence interval; OR, odds ratio.
Table VI. Calculation of VSGNE RAAA risk score
Variable OR Integer points
Age >76 5.3 2
Cardiac arrest 4.3 2
Loss of consciousness 2.7 1
Suprarenal clamp 2.4 1
VSGNE RAAA risk scorea 0-6
OR, Odds ratio; RAAA, ruptured abdominal aortic aneurysm; VSGNE,
Vascular Study Group of New England.
aSample case demonstrating calculation of the VSGNE RAAA risk score in
an 80-year-old man who had loss of consciousness but no cardiac arrest and
was repaired with suprarenal clamping of the aorta:
Age >76: 2 points
Cardiac arrest: 0 points
Loss of consciousness: 1 point
Suprarenal clamp: 1 point
VSGNE RAAA risk score ¼ 2 þ 0 þ 1 þ 1 ¼ 4
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patients, physicians, and third-party payers as a key index
procedure by which physicians and institutions can be eval-
uated.25 As with any outcome measure, accurate risk
adjustment is necessary to allow fair and valid comparison
between surgeons and institutions that may be treating
patients who are very different from each other. Risk-
adjusted outcomes also allow appropriate identiﬁcation of
areas for improvement in underperforming institutions.
Robust parsimonious models for predicting mortality after
repair of RAAAs are clearly needed.This report represents the ﬁrst attempt to externally
validate existing scoring systems in a U.S. population.
When tested in the VSGNE cohort, the discrimination
was generally good, with C-statistics ranging from 0.67
to 0.74. Calibration of the existing scoring systems was
acceptable in low-risk patients, as evidenced by nonsigniﬁ-
cant Hosmer-Lemeshow goodness-of-ﬁt tests. However,
all existing scoring systems failed to identify patients at
highest risk for mortality. For example, patients with a
Hardman index of 2 had 70% mortality. Those with a Hard-
man index $3, who therefore had a higher predicted
mortality risk, had an actual mortality of 50%. The highest
strata of risk scores according to the GAS (score $101),
Vancouver score ($.68), or ERAS (score ¼ 3) were
associated with mortality rates of 57%, 65%, and 50%
respectively. Based on this analysis, no existing scoring
system was able to identify consistently those patients
with >65% risk of mortality. This is consistent with
Table VII. Distribution of patients and mortality according to the VSGNE RAAA risk score
VSGNE risk score 0 1 2 3 4 5 6
No. of patients (%) 61 (25.2) 48 (19.8) 57 (23.6) 40 (16.5) 10 (4.1) 11 (4.5) 4 (1.7)
No. of deaths 5 12 21 24 8 10 3
RAAA, Ruptured abdominal aortic aneurysm; VSGNE, Vascular Study Group of New England.
Fig 1. Mortality rate according to the Vascular Study Group of
New England (VSGNE) ruptured abdominal aortic aneurysm
(RAAA) risk score.
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man index, and Vancouver score failed to identify patients
at highest mortality risk when tested in external popula-
tions.16,17,26 To our knowledge, this was the ﬁrst attempt
to validate the ERAS in any external cohort.
The VSGNE RAAA risk score, on the other hand,
showed superior discrimination (C ¼ .79; 95% CI, .73-
.85) than did existing scoring systems and excellent calibra-
tion, as it predicted risk well in both low- and high-risk
patients, such as those with $80% mortality risk. For
example, a VSGNE RAAA risk score of 4 was associated
with a mortality rate of 80%, whereas a VSGNE RAAA
risk score of 5 or 6 was associated with a mortality rate of
87%. In comparison to existing scoring systems, the
VSGNE RAAA risk score better identiﬁes patients at high-
est risk for mortality.
The VSGNE RAAA risk score (range, 0-6) is easily
calculated based on four variables readily assessed at the
time of presentation (Table VI). The existing scoring
systems incorporate variables that require knowledge of
the patients’ underlying conditions (GAS: cerebrovascular
disease, myocardial disease, renal disease) or additional
testing (Harman index: electrocardiographic ischemia,
creatinine), which may not be readily available at the time
of presentation of a patient with an RAAA.13-15 In addition,
the VSGNE RAAA risk score is easier to calculate than the
more cumbersome GAS and Vancouver score, without
the need for anything but simple addition of integer points
based on four dichotomous variables. In addition, based on
the fact that all four variables were successfully abstracted in
the VSGNE dataset in 231 patients (95%), these variables
are readily available for the purpose of risk adjustment at
the surgeon, institution, or regional level.In our multivariable model, age >76 years was most
strongly associated with mortality. This was consistent
with previous scoring systems, which identiﬁed advanced
age as a predictor of mortality, including the GAS, Hardman
index, and Vancouver score. We analyzed the impact of
increasing age in multiple ways. Analysis demonstrated
that “age >76” was the optimal cutoff in order to analyze
the impact of age as a dichotomous variable. We believed
that the ability to accurately model age as a dichotomous
variable was valuable because it would allow for creation
of a parsimonious risk score that clinicians could quickly
calculate. Inclusion of age as a continuous variable, as
done in the GAS and Vancouver score, requires more
complex calculation that we suspect many ﬁnd cumber-
some. Interestingly, our cutoff of 76 years was identical to
that used in the Hardman index and therefore allowed for
consistent head-to-head comparison of the two risk scores.
Preoperative cardiac arrest also strongly predicted
mortality. Only the Vancouver score included cardiac arrest
in the scoring system. The GAS identiﬁed “shock,” and the
ERAS identiﬁed “SBP<90mmHg” as similar variables that
predicted mortality. We analyzed multiple hemodynamic
parameters that identify shock (SBP <80 mm Hg,
SBP <90 mm Hg, and HR >100) in our multivariable
model, and none was predictive of mortality. “Hypotensive
hemostasis,” in which relative hypotension is tolerated
without aggressive ﬂuid resuscitation, has been increasingly
adopted. In the current era, preoperative shock as measured
by traditional parameters does not signiﬁcantly impact
mortality.
“Loss of consciousness” independently predicted mor-
tality. This variable was also identiﬁed by the Hardman
index, whereas the ERAS identiﬁed Glasgow coma scale
score <15, and the Vancouver score identiﬁed “reduced
conscious” as risk factors. When confronted with the need
for rapid decision making, clinicians can identify “loss of
consciousness”more readily and deﬁnitively than determine
Glasgow coma scale or “reduced consciousness.”
Finally, our analysis identiﬁed the need for a suprarenal
clamp as predictive of mortality. Previous studies have also
found that placement of a suprarenal aortic clamp has been
associated with worse outcomes after repair of both intact
and ruptured AAAs.27-30 Based on these data, it is impos-
sible to know if, in fact, a suprarenal clamp was necessitated
by the presence of a juxtarenal or pararenal aneurysm or
was used at the preference of the surgeon as an alternative
to infrarenal dissection and clamping in the setting of
extensive inframesocolic hematoma. Nevertheless, these
data suggest that the surgeon should avoid suprarenal
clamping when at all possible for an infrarenal AAA. In
addition, by accounting for the risk associated with the
Table VIII. Published risk scoring systems for open repair of RAAA
Risk score Formula
Glasgow aneurysm score Age þ 17 for shock þ 7 for myocardial disease þ 10 for cerebrovascular disease þ 14 for renal
disease
Hardman index Score from 1 to 5 depending on number of ﬁve risk factors present
Risk factors: age >76, electrocardiographic ischemia, creatinine >190 mmol/L, loss of
consciousness, hemoglobin (g/dL) <9
Vancouver score Ex/(1 þ Ex), where x ¼ (e3.44) þ [sum of coefﬁcients of signiﬁcant variables]
Variable Coefﬁcient
Age .062  age
Reduced consciousness: Yes 1.14
Reduced consciousness: No 1.14
Cardiac arrest: Yes .6
Cardiac arrest: No .6
Edinburg ruptured aneurysm score Score from 1 to 3 depending on number of three risk factors present
Risk factors: hemoglobin (g/dL) <9, preoperative Glasgow coma scale score <15, preoperative
systolic blood
pressure <90 mm Hg
RAAA, Ruptured abdominal aortic aneurysm.
Table IX. Performance of published risk scoring systems
in the VSGNE cohort
Model Calibrationa Discriminationb
Glasgow aneurysm score c2 ¼ 7.2, P ¼ .52 .74
Hardman index c2 ¼ .86, P ¼ .35 .72
Vancouver score c2 ¼ 14.5, P ¼ .07 .76
Edinburg ruptured
aneurysm score
c2 ¼ 1.55, P ¼ .2 .67
VSGNE RAAA risk score c2 ¼ 1.96, P ¼ .85 .79
RAAA, Ruptured abdominal aortic aneurysm; VSGNE, Vascular Study
Group of New England.
aHosmer-Lemeshow test.
bC-statistic.
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tially allows for comparison of outcomes in cohorts of
patients with ruptured AAAs treated with either open or
endovascular repair. The use of endovascular repair of
RAAAs increased from 5.9% in 2001 to 18.9% in 2006
according to data from Nationwide Inpatient Sample.3
This trend is likely to continue, as mortality of EVAR for
RAAAs has generally been reported to be signiﬁcantly
lower than that of open repair, ranging from 18.5% to
31.7%.3,31,32 Endovascular repair is generally used when
there is adequate nonaneurysmal infrarenal aortic neck,
whereas open repair is often used when there is an adverse
anatomy in the neck of the AAA that requires a suprarenal
clamp and therefore has increased risk of mortality.
Without accounting for the risk associated with suprarenal
clamping, valid comparison of the two strategies is difﬁcult,
as is comparison of cohorts of patients at different institu-
tions who may be at different risk of mortality.
The need for a suprarenal clamp can often be readily
identiﬁed based on computed tomographic scanning. In
modern algorithms for RAAA management, 78% to 93%
of patients undergo preoperative computed tomographicscan.32,33 Thus, the need for a suprarenal clamp can often
be readily identiﬁed preoperatively by the surgeon for
prognostic risk assessment or determined retrospectively
for use in risk adjustment for comparative audit. We believe
that the validity of the VSGNE RAAA risk score should be
tested in a cohort of patients undergoing endovascular
repair of ruptured AAAs. When EVAR is applied to patients
with an infrarenal AAA, zero points should be assigned for
the variable (suprarenal clamp), and the patient’s VSGNE
RAAA risk score would then be based on the other three
independent predictors represented in the model. If validity
in an endovascular cohort is established, the VSGNE
RAAA risk score will allow for risk-adjusted comparison
of EVAR and open repair of RAAA.34
There are limitations to this study. Although this data-
set was generated from a contemporary “real-world” expe-
rience of community hospitals and tertiary referral centers,
the size of the cohort is limited. There is also heterogeneity
between centers with regard to institutional volume,
resources, and institutional practices. In addition, the
VSGNE RAAA risk score was developed over a period of
signiﬁcant ﬂux in practice patterns, and patients under-
going open repair of ruptured AAAs today are likely at
higher risk. Some of the patients who underwent open
repair in this cohort may have been treated with endovas-
cular repair at other centers in the United States. Neverthe-
less, the VSGNE RAAA risk score is the ﬁrst risk score
developed and validated in a prospectively collected U.S.
cohort and the ﬁrst developed in the era of endovascular
repair of ruptured AAAs. External, prospective validation
in a larger dataset is required before this prediction model
can be recommended for risk stratiﬁcation or comparative
audit outside of the VSGNE. There is good evidence
that, with appropriate validation, parsimonious prediction
models based on a small number of important clinical vari-
ables provide risk adjustment of equivalent accuracy to
more complicated multivariable models.34
Fig 2. Mortality rate according to the Glasgow aneurysm score (GAS), Hardman index, Vancouver score, and
Edinburg ruptured aneurysm score (ERAS). Patients were grouped and analyzed according to total integer score for
the Hardman index and ERAS and according to quartile of increasing risk score for the GAS and Vancouver score.
VSGNE, Vascular Study Group of New England.
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When tested in the VSGNE cohort, the GAS, Hard-
man index, Vancouver score, and ERAS demonstrated
good overall correlation with mortality but were limited
in their ability to identify those patients at highest risk for
mortality. The VSGNE RAAA risk score is the ﬁrst risk
score developed and validated in a prospectively collected
U.S. cohort and the ﬁrst developed in the era of endovas-
cular repair of RAAAs. The VSGNE RAAA risk score
allows accurate prediction of mortality based on four vari-
ables readily assessed in current practice, including identiﬁ-
cation of those patients at the highest level of risk.
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vascular surgery. J Vasc Surg 2010;52:400-5.Submitted Jul 5, 2012; accepted Aug 28, 2012.INVITED COMMENTARYMagruder C. Donaldson, MD, Framingham, MassMortality rate following open repair of RAAA has hovered
between 40% and 70% for decades. Tragically, although surgeons
may get patients through surgery, all too often, the patients succumb
to the sequelae of aortic rupture and surgical stress. Using patient-
determined preoperative variables, several studies have proposed
scoring systems to predict mortality. Applied to cohorts of patients,
a validated scoring protocol would support improvements in care
and allowbetter comparative assessment of outcomes.Applied to indi-
vidual patients, an accurate predictivemodelmight enable surgeons to
manage expectations and resources more realistically and humanely.
The study from VSGNE brings a powerful tool to bear on this
problem. The analysis is strengthened by large numbers but is
tempered by lack of detail in some elements. Although the data
were gathered prospectively, the analysis was retrospective. Contin-
uous variables were grouped with cutoff points for analysis, thereby
covering subtleties and risking oversimpliﬁcation. For example, the
age cutoff of 76 obscures the intriguing ﬁnding that patients older
than 85did better than those between 80 and85.Despite some unan-
swered questions and the potential pitfalls of a paper comparison with
othermodels, the VSGNE systemmay be a real step forward, particu-
larly for patients in the highest risk category. At themoment, however,
it should be used with caution until it is prospectively validated.
The VSGNE study found that suprarenal (likely frequently
supraceliac) aortic clamping was a strong predictor of mortality.To be of prospective value in predicting mortality, the decision
regarding whether suprarenal clamp position would be anato-
mically obligatory (in the case of a pararenal or juxtarenal
RAAA) or a matter of the surgeon’s tactical discretion would
need to be made preoperatively, usually on the basis of CT, rather
than after incision, as was often likely the case in the series.
Although use of diagnostic CT is now commonplace, application
of this scoring element may not be practical in some circumstances.
In any case, the study ﬁndings should dissuade “elective” supra-
renal and supraceliac clamping when avoidable.
Most studies to date show that EVAR is associated with a lower
mortality rate than open repair. With seemingly improved survival
rates for the ﬁrst time in decades, it might be hoped we would
ﬁnd less need for predicting therapeutic futility. Also, it seems
unlikely that a predictive scoring system derived from open experi-
ence will be useful for patients undergoing EVAR. Assigning
a preoperative score of 0 for suprarenal clamping for EVAR patients
might shortchange the consequences of suprarenal balloon occlu-
sion not infrequently used during EVAR. More importantly, reper-
fusion, ﬂuid shifts, cardiorespiratory strain, and other components
of stress so typical of open repair provide a linkage with the VSGNE
predictors not likely duplicated in EVAR patients. Nonetheless,
further study by the VSGNE group with increased numbers of
patients treated by EVAR will be of great interest.
